MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer

Prostate cancer

(2016) Gerhardt Attard et al.   LANCET

microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression

(2015) Guangye Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer

(2015) Yunhui Hu et al.   BREAST CANCER RESEARCH AND TREATMENT

miRNA–mRNA pairs are differently expressed in African American men

(2015) Louise Stone   Nature Reviews Urology

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness

(2015) Helge Siemens et al.   Oncotarget

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6

(2014) Xiaolan Zhu et al.   INTERNATIONAL JOURNAL OF CANCER

Receptor-interacting Protein 1 Increases Chemoresistance by Maintaining Inhibitor of Apoptosis Protein Levels and Reducing Reactive Oxygen Species through a microRNA-146a-mediated Catalase Pathway

(2014) Qiong Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras

(2014) Zhumei Shi et al.   NEURO-ONCOLOGY

MiR-200, a new star miRNA in human cancer

(2013) Xiangling Feng et al.   CANCER LETTERS

Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials

(2013) Saroj Niraula et al.   JOURNAL OF CLINICAL ONCOLOGY

Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma

(2013) Wen Zhou et al.   Molecular Cancer

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1

(2013) Martje Tönjes et al.   NATURE MEDICINE

miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 Pathway

(2011) N. M. Alajez et al.   CANCER RESEARCH

The Tumor Suppressive MicroRNA miR-218 Targets the mTOR Component Rictor and Inhibits AKT Phosphorylation in Oral Cancer

(2011) A. Uesugi et al.   CANCER RESEARCH

A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma

(2011) Benjamin Ory et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells

(2011) Nerea Bitarte et al.   STEM CELLS

miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β

(2010) Libing Song et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

(2010) Dimitrios Iliopoulos et al.   MOLECULAR CELL

MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor

(2010) Jun Tie et al.   PLoS Genetics

Prostate cancer

(2008) Jan-Erik Damber et al.   LANCET

MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

(2008) G. Gabriely et al.   MOLECULAR AND CELLULAR BIOLOGY